We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: This replaces the announcement made at 17:45 on October 31 because the following statement has been deleted: “The limited review procedures for the interim financial statements...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.25 | 0.25 | 0.25 | 0 | 0 | DE |
4 | 0 | 0 | 0.25 | 0.25 | 0.25 | 0 | 0 | DE |
12 | -0.16 | -39.0243902439 | 0.41 | 0.439 | 0.23 | 7515 | 0.31664873 | DE |
26 | -0.224 | -47.2573839662 | 0.474 | 0.89 | 0.22 | 30623 | 0.52323396 | DE |
52 | -4.2 | -94.3820224719 | 4.45 | 5.3 | 0.22 | 51162 | 0.89178334 | DE |
156 | -5.55 | -95.6896551724 | 5.8 | 11 | 0.22 | 19224 | 1.51382142 | DE |
260 | 0.076 | 43.6781609195 | 0.174 | 11 | 0.142 | 59875 | 1.25188536 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions